VICTR Archives
Clinic helps adults clarify true status of penicillin allergy
Sep. 27, 2018—by Bill Snyder Two years ago when she was given a type of penicillin to fight off bacterial pneumonia, Kelly Cummins developed a rash, itching and shortness of breath. Suspecting she was having a reaction to the life-saving medication, her doctor stopped the penicillin and substituted a different class of antibiotic. Cummins recovered but now...
VUMC drug repurposing initiative gaining momentum
Apr. 19, 2018—Drug repurposing involves establishing an additional approved indication for a drug already at market.
Grant bolsters study of potential new therapy for C. diff infection
Mar. 22, 2018—According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.
Study reveals safety signal from genes that mimic drugs
Mar. 1, 2018—Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.
Exhibit translates scientific discoveries into art celebrating Vanderbilt’s Nobel laureates
Oct. 13, 2017—A new exhibit on display at the Wond'ry honors the discoveries of Vanderbilt's Nobel laureates by translating them into beautiful works of art.
New lab formulary improves quality, cuts cost
Sep. 21, 2017—An effort at Vanderbilt University Medical Center (VUMC) to enhance clinical decision making through cross-departmental collaboration and effective use of diagnostics has improved patient care and saved the institution more than $1 million in 2016, VUMC officials reported this week.
Community key to gender identity research effort
Sep. 7, 2017—One of the key elements of the Vanderbilt Program for LGBTI Health, an innovative effort to improve health care for lesbian, gay, bisexual, transgender and intersex patients, is community engagement.
Lindsell named to key VICTR, IMPH and Biostatistics leadership roles
Jul. 13, 2017—Christopher Lindsell, Ph.D., nationally known for building clinical, translational and emergency medicine research programs at the University of Cincinnati, has been named director of the Research Methods Program in the Vanderbilt Institute of Clinical and Translational Research (VICTR).
VUMC lands renewal of Clinical and Translational Science Award
Jun. 8, 2017—Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH).
New grants bolster Trauma program’s research initiatives
Feb. 9, 2017—Vanderbilt University Medical Center’s Division of Trauma, Emergency General Surgery and Surgical Critical Care was recently awarded two new research grants.
Plasmin prevents muscle ‘hardening’ after injury: study
Dec. 8, 2016—Vanderbilt researchers have made the surprising discovery that the protease plasmin, known for its clot-busting role in the blood, protects soft tissue from turning to bone after severe injuries and certain orthopaedic surgeries.
Harrell to step down as chair of Biostatistics
Jul. 19, 2016—Frank Harrell Jr., Ph.D., professor of Biostatistics and founding chair of Vanderbilt’s Department of Biostatistics in 2003, will step down as chair after the completion of a national search for his successor.
